Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Chongqing Zhifei Biological Products Co Ltd (Zhifei Biological) is a Biotech company. It focuses on the research, development, production, marketing, and distribution of vaccines for human use. The company's products include vaccines such as the recombinant novel coronavirus vaccine, recombinant mycobacterium tuberculosis fusion protein, and various meningococcal and hemophilus influenzae type b vaccines. Zhifei Biological's products are used by healthcare providers for disease prevention and diagnosis across various medical applications. It markets its vaccines under the brands Ekear, XiFeiBei, Menwayc, and Vaccae. Zhifei Biological is headquartered in Chongqing, China.
Headquarters
China
Address
50th Floor, No. 1 Yunlu Road, Chongqing, 400020
Website
www.zhifeishengwu.com
Telephone
86 23 86358226
No of Employees
6,292
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
300122 (SHE)
Revenue (2024)
$1.2B
-50.7%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-75%
(2024 vs 2023)
Market Cap*
$4.1B
Net Profit Margin (2023)
XYZ
-49.3%
(2024 vs 2023)
* As of and is in US$
Chongqing Zhifei Biological Products Co Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Recombinant Novel Coronavirus Vaccine | Warehousing and Supply Chain | Ekear |
| Recombinant Mycobacterium Tuberculosis Fusion Protein | Logistics and Distribution | XiFeiBei |
| Meningococcal and Hemophilus Influenzae Type b Vaccines | Menwayc | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | Chongqing Zhifei Biological Products Co Ltd | Beijing Tiantan Biological Products Co Ltd | Anhui Anke Biotechnology (Group) Co Ltd | BravoVax Co Ltd |
|---|---|---|---|---|
| Headquarters | China | China | China | China |
| City | Chongqing | Beijing | Hefei | Wuhan |
| State/Province | Chongqing | Beijing | Anhui | Hubei |
| No. of Employees | 6,292 | 5,205 | 2,505 | - |
| Entity Type | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jiang Rensheng | Chairman | Executive Board | 2021 | 73 |
| Jiang Lingfeng | Vice Chairman; President | Executive Board | 2024 | 46 |
| Li Zhenjing | Chief Financial Officer; Director; Vice President | Executive Board | 2018 | 44 |
| Qin Fei | Vice President; Secretary; Director | Executive Board | 2021 | 40 |
| Fan Hong | Vice President | Senior Management | 2024 | 38 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer